Mpex Pharmaceuticals Secures $27,500,000 Series D Round

  • Feed Type
  • Date
    2/10/2009
  • Company Name
    Mpex Pharmaceuticals
  • Mailing Address
    11535 Sorrento Valley Road San Diego, CA 92121
  • Company Description
    Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens.
  • Website
    http://www.mpexpharma.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,500,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.